Treatment Guide
Stem cell options by layover length
How protocol depth scales with the transit window — 90 minute IV-only, 4 hour IV plus microneedling, 8 hour full course — and which window fits your routing.
The single most important variable in transit-treatment planning is not the clinic, the protocol, or the price; it is the layover length, and the protocol depth has to scale honestly to fit it. A patient with a 4-hour Incheon connection cannot fit the same protocol as a patient with an 8-hour connection, and a patient who tries to compress the deeper protocol into the shorter window will either miss the connecting flight or compromise the clinical session. This page is the editorial guide to matching protocol depth to layover length, written by Ji-Won Choi for an audience of international travellers who want to know — before they book the inbound flight — which protocol their routing actually permits. The three windows I write to are the operational standards in airport-cluster transit practice: a 90-minute IV-only window for layovers between 4 and 5 hours, a 4-hour IV-plus-microneedling window for layovers between 6 and 8 hours, and an 8-hour full-course window for layovers between 10 and 12 hours. Each window has a defined operational envelope, a defined protocol depth, a defined pricing tier, and a defined recovery profile that interacts predictably with a long-haul connecting flight. Choosing the right window for the routing is the planning decision that matters; choosing the wrong window — typically by ambition — is the failure mode that costs either the connecting flight or the clinical response.
The 90-minute IV-only window — for 4 to 5 hour layovers
The shortest viable transit-treatment window is 90 minutes of in-clinic time, anchored to a 4 to 5 hour Incheon layover with carry-on-only luggage and a fast-track immigration line. The protocol that fits this window is an exosome IV (allogeneic exosome preparation, MFDS-supervised, delivered via standard IV cannulation over 30 to 45 minutes with a brief pre-IV consultation and a brief post-IV observation), or in some clinics a growth-factor mesotherapy (a series of microinjections of growth-factor concentrate into the dermis without microneedling-channel preparation). The IV-only protocol does not include microneedling or any energy-based delivery modality; the in-clinic time is too short to add topical anaesthesia, microneedling, and observation on top of the IV chair-time without compromising the connecting-flight buffer. The recovery profile is the gentlest in the transit-treatment range: no microchannelled skin barrier, no surface redness, no swelling beyond a small bruise at the IV site, and the patient can board the connecting long-haul flight within 60 to 90 minutes of clinic discharge without any cabin-pressure interaction concern. The clinical response profile is real but modest: exosome IV signals systemic regenerative cues that produce skin-quality improvement over the 4 to 12 weeks following the session, but the response is less pronounced than the response to combined IV-plus-microneedling protocols where the bio-active is delivered both systemically and locally. Patients choose the 90-minute window for two reasons: their layover is genuinely too short for anything deeper, or they are using the transit window as a maintenance booster on an established protocol that they began on a previous Seoul-stay trip. Both reasons are legitimate and both produce predictable outcomes within the modest response envelope.
The 4-hour IV-plus-microneedling window — for 6 to 8 hour layovers
The middle window — 4 hours of in-clinic time, anchored to a 6 to 8 hour Incheon layover — is where the transit-treatment protocol becomes genuinely interesting clinically and where most editorial recommendations for first-time transit patients land. The protocol that fits this window is exosome IV combined with exosome microneedling: 30 to 45 minutes of IV chair-time, 20 to 30 minutes of topical-anaesthesia application and absorption, 60 to 90 minutes of microneedling with topical exosome application post-channelling, and 15 to 30 minutes of post-procedure observation. The combined protocol delivers the bio-active both systemically (via IV) and locally (via micro-channelled skin), and the published Korean dermatology literature on combined-modality regenerative protocols supports the proposition that the combined response exceeds the response to either modality in isolation. The recovery profile is more pronounced than the IV-only profile: post-microneedling skin is pink for 6 to 24 hours, mildly swollen for 24 to 48 hours, and barrier-compromised for 24 to 72 hours. The patient can board a long-haul connecting flight within 90 to 120 minutes of clinic discharge — the cabin-pressure interaction with a microchannelled skin is manageable when aftercare is handled correctly (see the flight-ready aftercare page) — but the recovery during the flight requires deliberate hydration and moisturisation. The 4-hour window is the workhorse of transit-treatment practice and is the recommendation that most editorial guides converge on for layovers in this range; the response-to-effort ratio is the best in the transit-treatment landscape.
The 8-hour full-course window — for 10 to 12 hour layovers
The deepest viable transit-treatment window is 8 hours of in-clinic time, anchored to a 10 to 12 hour Incheon layover with carry-on-only luggage and either fast-track immigration or a same-day APEC-business-traveller routing. The protocol that fits this window is the full-course combined protocol: exosome IV, exosome microneedling, growth-factor mesotherapy, sometimes with a sequenced energy-based delivery modality (RF micro-channelling, fractional needles), and a more substantial post-procedure observation window with photo-documented response confirmation. Total in-clinic time runs 4 to 6 hours of active procedure plus 1 to 2 hours of intake, observation, and discharge. The 8-hour window approaches what a Seoul-staying patient would receive on a single-day intensive itinerary in Gangnam, with the difference that the transit patient does not have the option of a same-day return to the clinic for a complication review and is therefore subject to slightly more conservative protocol selection. The recovery profile is the most pronounced in the transit-treatment range: post-procedure pink for 12 to 36 hours, mild swelling for 48 to 72 hours, and a barrier-recovery window of 72 to 96 hours. The patient can still board the connecting long-haul flight within 90 to 120 minutes of discharge, but the in-flight recovery and the post-flight 48 to 72 hours at home require disciplined aftercare to preserve the response. The 8-hour window is appropriate for patients with a genuine 10 to 12 hour Incheon layover, not for patients trying to compress the depth into a shorter window; the operational margins do not support the compression.
Comparison table — protocol depth by layover length
Comparing the three windows side by side, the operational and clinical differentiation is straightforward: the 90-minute IV-only window suits 4 to 5 hour layovers and produces a modest response profile; the 4-hour IV-plus-microneedling window suits 6 to 8 hour layovers and produces the best response-to-effort ratio in transit practice; the 8-hour full-course window suits 10 to 12 hour layovers and produces a near-Seoul-stay response profile with the constraint that complication review is not same-day. Pricing scales with depth: 90-minute IV-only sits in the lower KRW band, 4-hour IV-plus-microneedling sits in the middle band, and 8-hour full-course sits in the upper band. Recovery scales with depth too: IV-only recovers within hours, IV-plus-microneedling recovers within 48 to 72 hours, full-course recovers within 72 to 96 hours. The connecting-flight buffer required is the same — 90 minutes outbound — across all three windows, because the buffer is operational rather than clinical. Patients choosing between windows should default to the longest window their routing genuinely permits, not the longest window their ambition wants to compress into; the editorial discipline here prevents the compression failure mode that produces either missed flights or compromised response.
When to skip the layover and book a Seoul stay instead
The transit windows are right for some patients and wrong for others, and editorial honesty requires writing the latter case. The transit window is wrong if the patient genuinely wants the deepest available regenerative protocol — the Seoul-stay protocols in Gangnam, Cheongdam, and Apgujeong run multi-day combined courses that the transit window cannot match, and the response-to-effort ratio of a five-day Gangnam itinerary exceeds the response-to-effort ratio of an 8-hour transit window for the patient who has the time. It is wrong if the patient has a complex medical history that warrants extended pre-procedure consultation. It is wrong if the patient is travelling with companions on a non-medical purpose and the layover treatment would compromise the trip's primary frame. And it is wrong if the patient is not flying through Incheon on the relevant routing and would need to add an Incheon stop specifically for the procedure — the marginal cost of a non-routine Incheon stop usually exceeds the marginal benefit of the transit window over a Seoul-stay protocol. Patients flying Asia-North America, Asia-Europe, or Asia-Oceania routings that already connect through Incheon are the genuine transit-window audience; patients adding an Incheon stop for the procedure are usually better served by a Seoul-stay itinerary.
How to know your routing actually permits the depth you want
The honest test of whether a routing permits a given protocol depth is the buffer arithmetic, and the editorial recommendation here is to write it out before booking the inbound flight. Take the scheduled inbound arrival time at Incheon. Add 90 to 120 minutes for immigration, baggage, and transfer. That gives the clinic chair-time start. Add the protocol's in-clinic envelope (90 minutes for IV-only, 4 hours for combined, 8 hours for full-course). That gives the clinic discharge time. Add 25 to 45 minutes for the return transfer to the airport. Add 90 minutes for outbound check-in, security, and gate-walk. That gives the latest tolerable connecting-flight boarding time. If the connecting-flight scheduled boarding time is later than the latest tolerable boarding time, the depth fits. If it is earlier, the depth does not fit, and the planning options are to book a shallower protocol, to choose a different connecting flight that lengthens the layover, or to defer to a Seoul-stay itinerary. The buffer arithmetic is unforgiving but it is the only honest test, and patients who write it out before booking are the patients who do not encounter the operational failure modes.
Frequently asked questions
Which window is the editorial recommendation for first-time transit patients?
The 4-hour IV-plus-microneedling window, for layovers between 6 and 8 hours. It produces the best response-to-effort ratio in transit-treatment practice, the recovery profile is well-managed by flight-ready aftercare, and the operational margins are comfortable. First-time transit patients should default to this window unless their layover is genuinely too short or genuinely long enough for the full course.
Can the 90-minute IV-only protocol produce visible results?
Yes, but the response profile is modest compared to combined protocols. Exosome IV signals systemic regenerative cues that produce skin-quality improvement over 4 to 12 weeks; the response is real but less pronounced than the combined IV-plus-microneedling response. The 90-minute window suits maintenance boosters on an established protocol or genuine 4 to 5 hour layovers; it should not be the editorial first choice for a patient who could instead book the 4-hour window.
Can I compress the 8-hour protocol into a 6-hour layover?
No. The 8-hour protocol envelope is operationally fixed: 4 to 6 hours of active procedure plus 1 to 2 hours of intake and observation. Compressing it into a 6-hour layover means either skipping intake (clinically inappropriate), skipping observation (clinically inappropriate), or running the procedure short (compromised response). The right protocol for a 6-hour layover is the 4-hour IV-plus-microneedling window.
What if my layover is 13 to 15 hours? Should I choose the 8-hour window?
Yes, the 8-hour window suits layovers up to roughly 14 hours. Beyond that the layover is long enough to consider a hotel and a more relaxed protocol pace, and the editorial recommendation crosses over to a brief Seoul-stay itinerary rather than a transit window. The 8-hour window is the upper bound of transit-treatment practice.
Does a microneedling protocol affect the connecting flight more than IV-only?
Yes, modestly. Microneedled skin is barrier-compromised for 24 to 72 hours and the cabin air on a long-haul flight is dehydrating; the recovery during the flight requires deliberate hydration and moisturisation. The flight is operationally permissible within 90 to 120 minutes of clinic discharge, but the in-flight aftercare is less passive than the IV-only flight. See the flight-ready aftercare page for the protocol.
Is the 4-hour window's response durable?
The IV-plus-microneedling response peaks at 4 to 8 weeks post-procedure and is durable through roughly 3 to 6 months in patients with typical response profiles. Patients who maintain the response with subsequent transit-window or Seoul-stay sessions extend the durability; patients who treat the single session as a one-off should expect the response to fade over 6 to 12 months. The clinical literature on exosome and growth-factor durability is still developing; the editorial framing here is conservative.
Can I have the deeper protocols if I have sensitive skin?
The protocol-depth selection should be made by the treating physician at the in-clinic consultation, not at booking, and patients with documented sensitive skin or active dermatologic conditions should disclose at booking. The treating physician may recommend a less aggressive microneedling depth, a shorter IV duration, or a deferral to a Seoul-stay protocol where extended consultation can be done. The transit window is not the place to override clinical judgement on protocol depth.
Are the pricing differences between windows meaningful?
Yes. The 90-minute IV-only window sits in the lower KRW band, the 4-hour combined window sits in the middle band, and the 8-hour full-course window sits in the upper band, with roughly 2x to 3x scaling between the floor and the ceiling. The pricing-tiers page documents the bands in KRW with USD, CNY, and JPY conversions; the bands are observable across multiple airport-cluster practices and represent realistic transit-window pricing rather than promotional figures.